Free public records show Nanjing Bioheng Biotech Co., Ltd. in 3 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Nanjing Bioheng Biotech Co., Ltd. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
5 active studies led by Nanjing Bioheng Biotech Co., Ltd., of 7 in all
Source: ClinicalTrials.gov, Studies with Nanjing Bioheng Biotech Co., Ltd. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Nanjing Bioheng Biotech Co., Ltd. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Nanjing Bioheng Biotech Co., Ltd. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Nanjing Bioheng Biotech Co., Ltd.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Nanjing Bioheng Biotech Co., Ltd. is in.
Stories on the topics Nanjing Bioheng Biotech Co., Ltd. works in.
2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a…
Read
170 of 194 WHO member states report use of traditional medicine. Herbal products are popular, but quality and…
Read
About 3 in 10 US adults sleep less than 7 hours. Melatonin helps with jet lag and shift work, but its effect…
ReadSearch all reports for Nanjing Bioheng Biotech Co., Ltd. All companies